Wolfe Research analyst Scott Group upgrades Matson (NYSE:MATX) from Underperform to Peer Perform.
Analyst Expectations for Rocket Pharmaceuticals’s Future
Rocket Pharmaceuticals (NASDAQ:RCKT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…